Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
472.65B | 439.02B | 441.22B | 442.07B | 374.64B | Gross Profit |
187.12B | 175.72B | 176.01B | 175.78B | 146.94B | EBIT |
24.10B | 22.02B | 25.79B | 30.92B | 20.06B | EBITDA |
39.07B | 36.56B | 39.93B | 44.59B | 31.99B | Net Income Common Stockholders |
14.05B | 13.23B | 15.59B | 18.65B | 11.83B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
11.72B | 9.22B | 12.24B | 14.68B | 11.98B | Total Assets |
458.56B | 419.25B | 398.08B | 395.10B | 378.26B | Total Debt |
184.10B | 158.80B | 147.38B | 147.06B | 150.63B | Net Debt |
172.38B | 149.58B | 135.14B | 132.38B | 138.66B | Total Liabilities |
301.30B | 269.70B | 255.63B | 261.81B | 254.18B | Stockholders Equity |
157.26B | 149.55B | 142.44B | 133.28B | 124.08B |
Cash Flow | Free Cash Flow | |||
3.74B | -6.22B | 6.35B | 20.31B | 15.62B | Operating Cash Flow |
22.49B | 9.40B | 17.44B | 35.12B | 26.69B | Investing Cash Flow |
-24.01B | -17.93B | -12.68B | -15.22B | -42.45B | Financing Cash Flow |
2.50B | 5.43B | -7.29B | -17.20B | 19.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €263.11B | 15.16 | 11.19% | 2.72% | 11.59% | 305.12% | |
74 Outperform | $583.33B | 21.80 | 10.45% | 1.09% | 17.94% | 18.31% | |
74 Outperform | ¥119.40B | 7.72 | 2.63% | 6.08% | 5.22% | ||
74 Outperform | ¥83.67B | 17.21 | 1.45% | 6.46% | 67.90% | ||
74 Outperform | $1.99T | 22.57 | 9.42% | 0.86% | ― | ― | |
61 Neutral | $6.69B | 11.69 | 3.01% | 3.94% | 2.60% | -21.51% |